Company intelligence / Profile preview
Clover Therapeutics
San Francisco, California, United Statespubsite-stg.clovertherapeutics.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Clover Therapeutics (now Character Biosciences) has demonstrated efficacy for its dry AMD drug candidates in animal models and is selecting candidates for advancement into clinical development. Genetic research in partnership with Genentech has informed their program.
- Therapeutic areas
- Ophthalmology
- Modalities
- ProteinBiologic
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
03
Partnerships
Genentech (Roche)
Beyond the preview
Go deeper on Clover Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Clover Therapeutics.